SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,419,000 | +8.6% | 305,279 | +6.7% | 0.01% | 0.0% |
| Q2 2017 | $3,148,000 | +16.5% | 286,147 | +3.8% | 0.01% | 0.0% |
| Q1 2017 | $2,702,000 | -14.2% | 275,728 | -5.5% | 0.01% | 0.0% |
| Q4 2016 | $3,150,000 | +0.4% | 291,685 | -4.7% | 0.01% | -16.7% |
| Q3 2016 | $3,137,000 | -47.7% | 306,093 | -33.4% | 0.01% | -45.5% |
| Q2 2016 | $6,001,000 | -21.2% | 459,419 | -33.7% | 0.01% | -21.4% |
| Q1 2016 | $7,619,000 | +28.7% | 692,674 | +7.7% | 0.01% | +55.6% |
| Q4 2015 | $5,919,000 | +111.7% | 643,389 | +59.7% | 0.01% | +125.0% |
| Q3 2015 | $2,796,000 | +21.7% | 402,948 | +72.2% | 0.00% | +33.3% |
| Q2 2015 | $2,298,000 | +1.1% | 234,062 | -8.8% | 0.00% | 0.0% |
| Q1 2015 | $2,274,000 | -19.5% | 256,681 | -20.4% | 0.00% | -25.0% |
| Q4 2014 | $2,824,000 | +109.8% | 322,339 | +65.0% | 0.00% | +100.0% |
| Q3 2014 | $1,346,000 | +163.9% | 195,402 | +101.5% | 0.00% | +100.0% |
| Q2 2014 | $510,000 | -20.4% | 96,971 | -31.2% | 0.00% | 0.0% |
| Q1 2014 | $641,000 | -36.8% | 140,963 | -30.0% | 0.00% | 0.0% |
| Q4 2013 | $1,015,000 | +95.6% | 201,465 | +96.7% | 0.00% | 0.0% |
| Q3 2013 | $519,000 | -20.6% | 102,444 | -22.4% | 0.00% | 0.0% |
| Q2 2013 | $654,000 | – | 131,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|